{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T13:09:45Z","timestamp":1785848985722,"version":"3.56.0"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004480","name":"Natural Science Foundation of Shanxi Province","doi-asserted-by":"publisher","award":["202203021221250"],"award-info":[{"award-number":["202203021221250"]}],"id":[{"id":"10.13039\/501100004480","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05771-x","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T09:17:06Z","timestamp":1730107026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["N6-Methyladenosine methylation modification in breast cancer: current insights"],"prefix":"10.1186","volume":"22","author":[{"given":"Guangwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinle","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4578-9423","authenticated-orcid":false,"given":"Shiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"5771_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"5771_CR2","doi-asserted-by":"publisher","first-page":"2515690x1983416","DOI":"10.1177\/2515690x19834169","volume":"24","author":"CA Abrah\u00e3o","year":"2019","unstructured":"Abrah\u00e3o CA, Bomfim E, Lopes-J\u00fanior LC, Pereira-da-Silva G. Complementary therapies as a strategy to reduce stress and stimulate immunity of women with breast cancer. J Evid Based Integr Med. 2019;24:2515690x19834169. https:\/\/doi.org\/10.1177\/2515690x19834169.","journal-title":"J Evid Based Integr Med"},{"issue":"8\u20139","key":"5771_CR3","first-page":"465","volume":"96","author":"H Rachdi","year":"2018","unstructured":"Rachdi H, Mokrani A, Batti R, Ayadi M, Chraiet N, Mezlini A. Target therapy for metastatic breast cancer. Tunis Med. 2018;96(8\u20139):465\u201371.","journal-title":"Tunis Med"},{"issue":"1","key":"5771_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer. 2020;19(1):53. https:\/\/doi.org\/10.1186\/s12943-020-01170-0.","journal-title":"Mol Cancer"},{"key":"5771_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.813581","volume":"10","author":"Y Mobet","year":"2022","unstructured":"Mobet Y, Liu X, Liu T, Yu J, Yi P. Interplay between m(6)A RNA methylation and regulation of metabolism in cancer. Front Cell Dev Biol. 2022;10: 813581. https:\/\/doi.org\/10.3389\/fcell.2022.813581.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"5771_CR6","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1053\/j.gastro.2020.11.013","volume":"160","author":"H Chen","year":"2021","unstructured":"Chen H, Gao S, Liu W, et al. RNA N(6)-methyladenosine methyltransferase METTL3 facilitates colorectal cancer by activating the m(6)A-GLUT1\u2013mTORC1 axis and is a therapeutic target. Gastroenterology. 2021;160(4):1284-1300.e16. https:\/\/doi.org\/10.1053\/j.gastro.2020.11.013.","journal-title":"Gastroenterology"},{"issue":"21","key":"5771_CR7","doi-asserted-by":"publisher","first-page":"12862","DOI":"10.1111\/jcmm.15938","volume":"24","author":"R Shen","year":"2020","unstructured":"Shen R. Commentary on metabolic reprogramming-associated genes predict overall survival for rectal cancer. J Cell Mol Med. 2020;24(21):12862\u20133. https:\/\/doi.org\/10.1111\/jcmm.15938.","journal-title":"J Cell Mol Med"},{"issue":"2","key":"5771_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gpb.2018.04.002","volume":"16","author":"S Liao","year":"2018","unstructured":"Liao S, Sun H, Xu C. YTH domain: a family of N(6)-methyladenosine (m(6)A) readers. Genom Proteom Bioinform. 2018;16(2):99\u2013107. https:\/\/doi.org\/10.1016\/j.gpb.2018.04.002.","journal-title":"Genom Proteom Bioinform"},{"issue":"19","key":"5771_CR9","doi-asserted-by":"publisher","first-page":"5735","DOI":"10.1093\/nar\/18.19.5735","volume":"18","author":"JE Harper","year":"1990","unstructured":"Harper JE, Miceli SM, Roberts RJ, Manley JL. Sequence specificity of the human mRNA N6-adenosine methylase in vitro. Nucleic Acids Res. 1990;18(19):5735\u201341. https:\/\/doi.org\/10.1093\/nar\/18.19.5735.","journal-title":"Nucleic Acids Res"},{"issue":"19","key":"5771_CR10","doi-asserted-by":"publisher","first-page":"14701","DOI":"10.1074\/jbc.M110.104711","volume":"285","author":"Z Zhang","year":"2010","unstructured":"Zhang Z, Theler D, Kaminska KH, et al. The YTH domain is a novel RNA binding domain. J Biol Chem. 2010;285(19):14701\u201310. https:\/\/doi.org\/10.1074\/jbc.M110.104711.","journal-title":"J Biol Chem"},{"issue":"11","key":"5771_CR11","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nchembio.1654","volume":"10","author":"C Xu","year":"2014","unstructured":"Xu C, Wang X, Liu K, et al. Structural basis for selective binding of m6A RNA by the YTHDC1 YTH domain. Nat Chem Biol. 2014;10(11):927\u20139. https:\/\/doi.org\/10.1038\/nchembio.1654.","journal-title":"Nat Chem Biol"},{"issue":"2","key":"5771_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/15476286.2016.1267096","volume":"14","author":"S Nachtergaele","year":"2017","unstructured":"Nachtergaele S, He C. The emerging biology of RNA post-transcriptional modifications. RNA Biol. 2017;14(2):156\u201363. https:\/\/doi.org\/10.1080\/15476286.2016.1267096.","journal-title":"RNA Biol"},{"issue":"4","key":"5771_CR13","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1261\/rna.064063.117","volume":"24","author":"E Sch\u00f6ller","year":"2018","unstructured":"Sch\u00f6ller E, Weichmann F, Treiber T, et al. Interactions, localization, and phosphorylation of the m(6)A generating METTL3\u2013METTL14\u2013WTAP complex. RNA. 2018;24(4):499\u2013512. https:\/\/doi.org\/10.1261\/rna.064063.117.","journal-title":"RNA"},{"issue":"7608","key":"5771_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nature18298","volume":"534","author":"X Wang","year":"2016","unstructured":"Wang X, Feng J, Xue Y, et al. Structural basis of N(6)-adenosine methylation by the METTL3\u2013METTL14 complex. Nature. 2016;534(7608):575\u20138. https:\/\/doi.org\/10.1038\/nature18298.","journal-title":"Nature"},{"issue":"2","key":"5771_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nchembio.1432","volume":"10","author":"J Liu","year":"2014","unstructured":"Liu J, Yue Y, Han D, et al. A METTL3\u2013METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation. Nat Chem Biol. 2014;10(2):93\u20135. https:\/\/doi.org\/10.1038\/nchembio.1432.","journal-title":"Nat Chem Biol"},{"issue":"5\u20136","key":"5771_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1101\/gad.309146.117","volume":"32","author":"P Knuckles","year":"2018","unstructured":"Knuckles P, Lence T, Haussmann IU, et al. Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d. Genes Dev. 2018;32(5\u20136):415\u201329. https:\/\/doi.org\/10.1101\/gad.309146.117.","journal-title":"Genes Dev"},{"key":"5771_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","volume":"4","author":"Y Yue","year":"2018","unstructured":"Yue Y, Liu J, Cui X, et al. VIRMA mediates preferential m(6)A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation. Cell Discov. 2018;4:10. https:\/\/doi.org\/10.1038\/s41421-018-0019-0.","journal-title":"Cell Discov"},{"issue":"7620","key":"5771_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature19342","volume":"537","author":"DP Patil","year":"2016","unstructured":"Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression. Nature. 2016;537(7620):369\u201373. https:\/\/doi.org\/10.1038\/nature19342.","journal-title":"Nature"},{"key":"5771_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","volume":"33","author":"KD Meyer","year":"2017","unstructured":"Meyer KD, Jaffrey SR. Rethinking m(6)A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319\u201342. https:\/\/doi.org\/10.1146\/annurev-cellbio-100616-060758.","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"6","key":"5771_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","volume":"71","author":"J Wei","year":"2018","unstructured":"Wei J, Liu F, Lu Z, et al. Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm. Mol Cell. 2018;71(6):973-985.e5. https:\/\/doi.org\/10.1016\/j.molcel.2018.08.011.","journal-title":"Mol Cell"},{"issue":"6","key":"5771_CR21","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, et al. N(6)-Methyladenosine modulates messenger RNA translation efficiency. Cell. 2015;161(6):1388\u201399. https:\/\/doi.org\/10.1016\/j.cell.2015.05.014.","journal-title":"Cell"},{"key":"5771_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.sbi.2017.05.011","volume":"47","author":"B Wu","year":"2017","unstructured":"Wu B, Li L, Huang Y, Ma J, Min J. Readers, writers and erasers of N(6)-methylated adenosine modification. Curr Opin Struct Biol. 2017;47:67\u201376. https:\/\/doi.org\/10.1016\/j.sbi.2017.05.011.","journal-title":"Curr Opin Struct Biol"},{"issue":"7646","key":"5771_CR23","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nature21671","volume":"543","author":"Y Xiang","year":"2017","unstructured":"Xiang Y, Laurent B, Hsu CH, et al. RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response. Nature. 2017;543(7646):573\u20136. https:\/\/doi.org\/10.1038\/nature21671.","journal-title":"Nature"},{"issue":"9","key":"5771_CR24","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res. 2017;27(9):1115\u201327. https:\/\/doi.org\/10.1038\/cr.2017.99.","journal-title":"Cell Res"},{"issue":"3","key":"5771_CR25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/cr.2017.15","volume":"27","author":"H Shi","year":"2017","unstructured":"Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA. Cell Res. 2017;27(3):315\u201328. https:\/\/doi.org\/10.1038\/cr.2017.15.","journal-title":"Cell Res"},{"issue":"7748","key":"5771_CR26","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41586-019-1016-7","volume":"567","author":"H Huang","year":"2019","unstructured":"Huang H, Weng H, Zhou K, et al. Histone H3 trimethylation at lysine 36 guides m(6)A RNA modification co-transcriptionally. Nature. 2019;567(7748):414\u20139. https:\/\/doi.org\/10.1038\/s41586-019-1016-7.","journal-title":"Nature"},{"issue":"1","key":"5771_CR27","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6(1):74. https:\/\/doi.org\/10.1038\/s41392-020-00450-x.","journal-title":"Signal Transduct Target Ther"},{"key":"5771_CR28","doi-asserted-by":"publisher","first-page":"8596135","DOI":"10.1155\/2017\/8596135","volume":"2017","author":"A Shah","year":"2017","unstructured":"Shah A, Rashid F, Awan HM, et al. The DEAD-Box RNA helicase DDX3 interacts with m(6)A RNA demethylase ALKBH5. Stem Cells Int. 2017;2017:8596135. https:\/\/doi.org\/10.1155\/2017\/8596135.","journal-title":"Stem Cells Int"},{"issue":"12","key":"5771_CR29","doi-asserted-by":"publisher","first-page":"9753","DOI":"10.3390\/cimb45120609","volume":"45","author":"R Youssef","year":"2023","unstructured":"Youssef R, Maniar R, Khan J, Mesa H. Metabolic interplay in the tumor microenvironment: implications for immune function and anticancer response. Curr Issues Mol Biol. 2023;45(12):9753\u201367. https:\/\/doi.org\/10.3390\/cimb45120609.","journal-title":"Curr Issues Mol Biol"},{"key":"5771_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.607224","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Qiu D, Yu A, et al. YTHDF1 is a potential pan-cancer biomarker for prognosis and immunotherapy. Front Oncol. 2021;11: 607224. https:\/\/doi.org\/10.3389\/fonc.2021.607224.","journal-title":"Front Oncol"},{"issue":"1","key":"5771_CR31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-021-01447-y","volume":"21","author":"W Wan","year":"2022","unstructured":"Wan W, Ao X, Chen Q, et al. METTL3\/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N(6)-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol Cancer. 2022;21(1):60. https:\/\/doi.org\/10.1186\/s12943-021-01447-y.","journal-title":"Mol Cancer"},{"key":"5771_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.785058","volume":"10","author":"M Dong","year":"2022","unstructured":"Dong M, Shen W, Yang G, Yang Z, Li X. Analysis of m6A methylation modification patterns and tumor immune microenvironment in breast cancer. Front Cell Dev Biol. 2022;10: 785058. https:\/\/doi.org\/10.3389\/fcell.2022.785058.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"5771_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40364-021-00295-8","volume":"9","author":"F Zheng","year":"2021","unstructured":"Zheng F, Du F, Zhao J, et al. The emerging role of RNA N6-methyladenosine methylation in breast cancer. Biomark Res. 2021;9(1):39. https:\/\/doi.org\/10.1186\/s40364-021-00295-8.","journal-title":"Biomark Res"},{"issue":"6","key":"5771_CR34","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.ccell.2020.10.004","volume":"38","author":"G Chang","year":"2020","unstructured":"Chang G, Shi L, Ye Y, et al. YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis. Cancer Cell. 2020;38(6):857-871.e7. https:\/\/doi.org\/10.1016\/j.ccell.2020.10.004.","journal-title":"Cancer Cell"},{"issue":"3","key":"5771_CR35","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","volume":"62","author":"S Lin","year":"2016","unstructured":"Lin S, Choe J, Du P, Triboulet R, Gregory RI. The m(6)A methyltransferase METTL3 promotes translation in human cancer cells. Mol Cell. 2016;62(3):335\u201345. https:\/\/doi.org\/10.1016\/j.molcel.2016.03.021.","journal-title":"Mol Cell"},{"key":"5771_CR36","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87283","author":"C Yan","year":"2023","unstructured":"Yan C, Xiong J, Zhou Z, et al. A cleaved METTL3 potentiates the METTL3\u2013WTAP interaction and breast cancer progression. Elife. 2023. https:\/\/doi.org\/10.7554\/eLife.87283.","journal-title":"Elife"},{"issue":"1","key":"5771_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13046-022-02581-1","volume":"42","author":"Y Xu","year":"2023","unstructured":"Xu Y, Song M, Hong Z, et al. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. J Exp Clin Cancer Res. 2023;42(1):10. https:\/\/doi.org\/10.1186\/s13046-022-02581-1.","journal-title":"J Exp Clin Cancer Res"},{"key":"5771_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216846","volume":"596","author":"J Wang","year":"2024","unstructured":"Wang J, Fan P, Shen P, et al. XBP1s activates METTL3\/METTL14 for ER-phagy and paclitaxel sensitivity regulation in breast cancer. Cancer Lett. 2024;596: 216846. https:\/\/doi.org\/10.1016\/j.canlet.2024.216846.","journal-title":"Cancer Lett"},{"issue":"1","key":"5771_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13058-022-01598-w","volume":"25","author":"D Ouyang","year":"2023","unstructured":"Ouyang D, Hong T, Fu M, et al. METTL3 depletion contributes to tumour progression and drug resistance via N6 methyladenosine-dependent mechanism in HR+HER2-breast cancer. Breast Cancer Res. 2023;25(1):19. https:\/\/doi.org\/10.1186\/s13058-022-01598-w.","journal-title":"Breast Cancer Res"},{"key":"5771_CR40","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3389\/fonc.2020.01126","volume":"10","author":"Y Shi","year":"2020","unstructured":"Shi Y, Zheng C, Jin Y, et al. Reduced expression of METTL3 promotes metastasis of triple-negative breast cancer by m6A methylation-mediated COL3A1 up-regulation. Front Oncol. 2020;10:1126. https:\/\/doi.org\/10.3389\/fonc.2020.01126.","journal-title":"Front Oncol"},{"issue":"11","key":"5771_CR41","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1158\/0008-5472.Can-20-3779","volume":"81","author":"F Chen","year":"2021","unstructured":"Chen F, Chen Z, Guan T, et al. N(6)-Methyladenosine regulates mRNA stability and translation efficiency of KRT7 to promote breast cancer lung metastasis. Cancer Res. 2021;81(11):2847\u201360. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-3779.","journal-title":"Cancer Res"},{"issue":"4","key":"5771_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/mabi.202000382","volume":"21","author":"XJ Zhu","year":"2021","unstructured":"Zhu XJ, Feng JQ, Zheng MZ, et al. Metal-protein nanoparticles facilitate anti-VSV and H1N1 viruses through the coordinative actions on innate immune responses and METTL14. Macromol Biosci. 2021;21(4): e2000382. https:\/\/doi.org\/10.1002\/mabi.202000382.","journal-title":"Macromol Biosci"},{"issue":"7860","key":"5771_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-021-03536-w","volume":"593","author":"E Yankova","year":"2021","unstructured":"Yankova E, Blackaby W, Albertella M, et al. Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia. Nature. 2021;593(7860):597\u2013601. https:\/\/doi.org\/10.1038\/s41586-021-03536-w.","journal-title":"Nature"},{"issue":"7","key":"5771_CR44","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/s41417-021-00390-w","volume":"29","author":"C Zhao","year":"2022","unstructured":"Zhao C, Ling X, Xia Y, Yan B, Guan Q. LncRNA UCA1 promotes SOX12 expression in breast cancer by regulating m(6)A modification of miR-375 by METTL14 through DNA methylation. Cancer Gene Ther. 2022;29(7):1043\u201355. https:\/\/doi.org\/10.1038\/s41417-021-00390-w.","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"5771_CR45","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.3892\/or.2020.7515","volume":"43","author":"D Yi","year":"2020","unstructured":"Yi D, Wang R, Shi X, Xu L, Yilihamu Y, Sang J. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6-methyladenosine and hsa-miR-146a-5p expression. Oncol Rep. 2020;43(5):1375\u201386. https:\/\/doi.org\/10.3892\/or.2020.7515.","journal-title":"Oncol Rep"},{"key":"5771_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.578963","volume":"10","author":"PJ Gong","year":"2020","unstructured":"Gong PJ, Shao YC, Yang Y, et al. Analysis of N6-methyladenosine methyltransferase reveals METTL14 and ZC3H13 as tumor suppressor genes in breast cancer. Front Oncol. 2020;10: 578963. https:\/\/doi.org\/10.3389\/fonc.2020.578963.","journal-title":"Front Oncol"},{"issue":"1","key":"5771_CR47","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-019-1053-8","volume":"18","author":"Y Chen","year":"2019","unstructured":"Chen Y, Peng C, Chen J, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1. Mol Cancer. 2019;18(1):127. https:\/\/doi.org\/10.1186\/s12943-019-1053-8.","journal-title":"Mol Cancer"},{"issue":"20","key":"5771_CR48","doi-asserted-by":"publisher","first-page":"5268","DOI":"10.1158\/0008-5472.Can-21-0494","volume":"81","author":"J Deng","year":"2021","unstructured":"Deng J, Zhang J, Ye Y, et al. N(6)-Methyladenosine-mediated upregulation of WTAPP1 promotes WTAP translation and Wnt signaling to facilitate pancreatic cancer progression. Cancer Res. 2021;81(20):5268\u201383. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-0494.","journal-title":"Cancer Res"},{"issue":"9","key":"5771_CR49","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1136\/gutjnl-2014-308614","volume":"65","author":"J Zhang","year":"2016","unstructured":"Zhang J, Tsoi H, Li X, et al. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP\u2013WT1\u2013TBL1 axis. Gut. 2016;65(9):1482\u201393. https:\/\/doi.org\/10.1136\/gutjnl-2014-308614.","journal-title":"Gut"},{"key":"5771_CR50","doi-asserted-by":"publisher","first-page":"6191","DOI":"10.2147\/ott.S205730","volume":"12","author":"HL Yu","year":"2019","unstructured":"Yu HL, Ma XD, Tong JF, Li JQ, Guan XJ, Yang JH. WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells. Onco Targets Ther. 2019;12:6191\u2013201. https:\/\/doi.org\/10.2147\/ott.S205730.","journal-title":"Onco Targets Ther"},{"issue":"1\u20132","key":"5771_CR51","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-022-01784-3","volume":"28","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhang L, Sun XL, et al. NRP1 contributes to stemness and potentiates radioresistance via WTAP-mediated m6A methylation of Bcl-2 mRNA in breast cancer. Apoptosis. 2023;28(1\u20132):233\u201346. https:\/\/doi.org\/10.1007\/s10495-022-01784-3.","journal-title":"Apoptosis"},{"key":"5771_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00834-8","author":"CG Lv","year":"2023","unstructured":"Lv CG, Cheng Y, Zhang L, et al. EXOSC2 mediates the pro-tumor role of WTAP in breast cancer cells via activating the Wnt\/\u03b2-catenin signal. Mol Biotechnol. 2023. https:\/\/doi.org\/10.1007\/s12033-023-00834-8.","journal-title":"Mol Biotechnol"},{"issue":"9","key":"5771_CR53","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41417-020-0160-4","volume":"27","author":"L Melstrom","year":"2020","unstructured":"Melstrom L, Chen J. RNA N(6)-methyladenosine modification in solid tumors: new therapeutic frontiers. Cancer Gene Ther. 2020;27(9):625\u201333. https:\/\/doi.org\/10.1038\/s41417-020-0160-4.","journal-title":"Cancer Gene Ther"},{"key":"5771_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01235-w","author":"SH Park","year":"2024","unstructured":"Park SH, Ju JS, Woo H, et al. The m(6)A writer RBM15 drives the growth of triple-negative breast cancer cells through the stimulation of serine and glycine metabolism. Exp Mol Med. 2024. https:\/\/doi.org\/10.1038\/s12276-024-01235-w.","journal-title":"Exp Mol Med"},{"key":"5771_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.918522","volume":"13","author":"T Wang","year":"2022","unstructured":"Wang T, Bai J, Zhang Y, Xue Y, Peng Q. N(6)-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma. Front Immunol. 2022;13: 918522. https:\/\/doi.org\/10.3389\/fimmu.2022.918522.","journal-title":"Front Immunol"},{"issue":"1","key":"5771_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","volume":"18","author":"XY Chen","year":"2019","unstructured":"Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103. https:\/\/doi.org\/10.1186\/s12943-019-1033-z.","journal-title":"Mol Cancer"},{"issue":"10","key":"5771_CR57","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202255506","volume":"24","author":"N Li","year":"2023","unstructured":"Li N, Zhu Z, Deng Y, et al. KIAA1429\/VIRMA promotes breast cancer progression by m(6) A-dependent cytosolic HAS2 stabilization. EMBO Rep. 2023;24(10): e55506. https:\/\/doi.org\/10.15252\/embr.202255506.","journal-title":"EMBO Rep"},{"issue":"33","key":"5771_CR58","doi-asserted-by":"publisher","first-page":"6123","DOI":"10.1038\/s41388-019-0861-z","volume":"38","author":"JY Qian","year":"2019","unstructured":"Qian JY, Gao J, Sun X, et al. KIAA1429 acts as an oncogenic factor in breast cancer by regulating CDK1 in an N6-methyladenosine-independent manner. Oncogene. 2019;38(33):6123\u201341. https:\/\/doi.org\/10.1038\/s41388-019-0861-z.","journal-title":"Oncogene"},{"key":"5771_CR59","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtn.2021.08.009","volume":"27","author":"X Zhang","year":"2022","unstructured":"Zhang X, Dai XY, Qian JY, et al. SMC1A regulated by KIAA1429 in m6A-independent manner promotes EMT progress in breast cancer. Mol Ther Nucleic Acids. 2022;27:133\u201346. https:\/\/doi.org\/10.1016\/j.omtn.2021.08.009.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"5771_CR60","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12943-020-01204-7","volume":"19","author":"T Wang","year":"2020","unstructured":"Wang T, Kong S, Tao M, Ju S. The potential role of RNA N6-methyladenosine in cancer progression. Mol Cancer. 2020;19(1):88. https:\/\/doi.org\/10.1186\/s12943-020-01204-7.","journal-title":"Mol Cancer"},{"issue":"9","key":"5771_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222336","volume":"14","author":"Y Funakoshi","year":"2019","unstructured":"Funakoshi Y, Wang Y, Semba T, et al. Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype. PLoS ONE. 2019;14(9): e0222336. https:\/\/doi.org\/10.1371\/journal.pone.0222336.","journal-title":"PLoS ONE"},{"issue":"1","key":"5771_CR62","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","volume":"31","author":"Z Li","year":"2017","unstructured":"Li Z, Weng H, Su R, et al. FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase. Cancer Cell. 2017;31(1):127\u201341. https:\/\/doi.org\/10.1016\/j.ccell.2016.11.017.","journal-title":"Cancer Cell"},{"key":"5771_CR63","doi-asserted-by":"publisher","first-page":"396","DOI":"10.3389\/fendo.2018.00396","volume":"9","author":"X Deng","year":"2018","unstructured":"Deng X, Su R, Stanford S, Chen J. Critical enzymatic functions of FTO in obesity and cancer. Front Endocrinol. 2018;9:396. https:\/\/doi.org\/10.3389\/fendo.2018.00396.","journal-title":"Front Endocrinol"},{"issue":"10","key":"5771_CR64","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/cac2.12075","volume":"40","author":"Y Xu","year":"2020","unstructured":"Xu Y, Ye S, Zhang N, et al. The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer. Cancer Commun. 2020;40(10):484\u2013500. https:\/\/doi.org\/10.1002\/cac2.12075.","journal-title":"Cancer Commun"},{"key":"5771_CR65","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.580036","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang S, Zou X, Chen Y, Cho WC, Zhou X. Effect of N6-methyladenosine regulators on progression and prognosis of triple-negative breast cancer. Front Genet. 2020;11: 580036. https:\/\/doi.org\/10.3389\/fgene.2020.580036.","journal-title":"Front Genet"},{"issue":"1","key":"5771_CR66","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12943-019-1004-4","volume":"18","author":"Y Niu","year":"2019","unstructured":"Niu Y, Lin Z, Wan A, et al. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3. Mol Cancer. 2019;18(1):46. https:\/\/doi.org\/10.1186\/s12943-019-1004-4.","journal-title":"Mol Cancer"},{"issue":"10","key":"5771_CR67","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41419-022-05317-3","volume":"13","author":"B Ou","year":"2022","unstructured":"Ou B, Liu Y, Gao Z, et al. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation. Cell Death Dis. 2022;13(10):905. https:\/\/doi.org\/10.1038\/s41419-022-05317-3.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5771_CR68","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang S, Zhao BS, Zhou A, et al. m(6)A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell. 2017;31(4):591-606.e6. https:\/\/doi.org\/10.1016\/j.ccell.2017.02.013.","journal-title":"Cancer Cell"},{"issue":"1","key":"5771_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.stem.2020.04.001","volume":"27","author":"J Wang","year":"2020","unstructured":"Wang J, Li Y, Wang P, et al. Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C\u2013ALKBH5\u2013AXL signaling axis. Cell Stem Cell. 2020;27(1):81-97.e8. https:\/\/doi.org\/10.1016\/j.stem.2020.04.001.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"5771_CR70","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15476286.2020.1804697","volume":"18","author":"YJ Wang","year":"2021","unstructured":"Wang YJ, Yang B, Lai Q, et al. Reprogramming of m(6)A epitranscriptome is crucial for shaping of transcriptome and proteome in response to hypoxia. RNA Biol. 2021;18(1):131\u201343. https:\/\/doi.org\/10.1080\/15476286.2020.1804697.","journal-title":"RNA Biol"},{"issue":"14","key":"5771_CR71","doi-asserted-by":"publisher","first-page":"E2047","DOI":"10.1073\/pnas.1602883113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang C, Samanta D, Lu H, et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA. Proc Natl Acad Sci USA. 2016;113(14):E2047\u201356. https:\/\/doi.org\/10.1073\/pnas.1602883113.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"5771_CR72","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.1158\/0008-5472.Can-22-0800","volume":"82","author":"H Liu","year":"2022","unstructured":"Liu H, Lyu H, Jiang G, et al. ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast cancer. Cancer Res. 2022;82(21):3974\u201386. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-0800.","journal-title":"Cancer Res"},{"key":"5771_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102993","volume":"69","author":"X Liu","year":"2024","unstructured":"Liu X, Li P, Huang Y, et al. M(6)A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer. Redox Biol. 2024;69: 102993. https:\/\/doi.org\/10.1016\/j.redox.2023.102993.","journal-title":"Redox Biol"},{"issue":"8","key":"5771_CR74","first-page":"2546","volume":"10","author":"R Anita","year":"2020","unstructured":"Anita R, Paramasivam A, Priyadharsini JV, Chitra S. The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients. Am J Cancer Res. 2020;10(8):2546\u201354.","journal-title":"Am J Cancer Res"},{"issue":"7","key":"5771_CR75","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1093\/nar\/gkaa048","volume":"48","author":"T Liu","year":"2020","unstructured":"Liu T, Wei Q, Jin J, et al. The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation. Nucleic Acids Res. 2020;48(7):3816\u201331. https:\/\/doi.org\/10.1093\/nar\/gkaa048.","journal-title":"Nucleic Acids Res"},{"key":"5771_CR76","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3389\/fonc.2019.00332","volume":"9","author":"Y Bai","year":"2019","unstructured":"Bai Y, Yang C, Wu R, et al. YTHDF1 regulates tumorigenicity and cancer stem cell-like activity in human colorectal carcinoma. Front Oncol. 2019;9:332. https:\/\/doi.org\/10.3389\/fonc.2019.00332.","journal-title":"Front Oncol"},{"issue":"1","key":"5771_CR77","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/s41467-019-12801-6","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi Y, Fan S, Wu M, et al. YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression. Nat Commun. 2019;10(1):4892. https:\/\/doi.org\/10.1038\/s41467-019-12801-6.","journal-title":"Nat Commun"},{"issue":"10","key":"5771_CR78","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1158\/0008-5472.Can-20-0066","volume":"81","author":"J Pi","year":"2021","unstructured":"Pi J, Wang W, Ji M, et al. YTHDF1 promotes gastric carcinogenesis by controlling translation of FZD7. Can Res. 2021;81(10):2651\u201365. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0066.","journal-title":"Can Res"},{"issue":"3","key":"5771_CR79","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41419-022-04711-1","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X, Li W, Li L, et al. YTHDF1 upregulation mediates hypoxia-dependent breast cancer growth and metastasis through regulating PKM2 to affect glycolysis. Cell Death Dis. 2022;13(3):258. https:\/\/doi.org\/10.1038\/s41419-022-04711-1.","journal-title":"Cell Death Dis"},{"issue":"3","key":"5771_CR80","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41419-022-04672-5","volume":"13","author":"Y Sun","year":"2022","unstructured":"Sun Y, Dong D, Xia Y, Hao L, Wang W, Zhao C. YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance. Cell Death Dis. 2022;13(3):230. https:\/\/doi.org\/10.1038\/s41419-022-04672-5.","journal-title":"Cell Death Dis"},{"key":"5771_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.667543","volume":"8","author":"Y Hu","year":"2021","unstructured":"Hu Y, Pan Q, Wang M, et al. m(6)A RNA methylation regulator YTHDF1 correlated with immune microenvironment predicts clinical outcomes and therapeutic efficacy in breast cancer. Front Med. 2021;8: 667543. https:\/\/doi.org\/10.3389\/fmed.2021.667543.","journal-title":"Front Med"},{"issue":"1","key":"5771_CR82","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/s41467-021-21514-8","volume":"12","author":"H Yin","year":"2021","unstructured":"Yin H, Zhang X, Yang P, et al. RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming. Nat Commun. 2021;12(1):1394. https:\/\/doi.org\/10.1038\/s41467-021-21514-8.","journal-title":"Nat Commun"},{"issue":"17","key":"5771_CR83","doi-asserted-by":"publisher","first-page":"9656","DOI":"10.3390\/ijms23179656","volume":"23","author":"Y Li","year":"2022","unstructured":"Li Y, Wang NX, Yin C, Jiang SS, Li JC, Yang SY. RNA editing enzyme ADAR1 regulates METTL3 in an editing dependent manner to promote breast cancer progression via METTL3\/ARHGAP5\/YTHDF1 axis. Int J Mol Sci. 2022;23(17):9656. https:\/\/doi.org\/10.3390\/ijms23179656.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5771_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13578-022-00759-w","volume":"12","author":"H Chen","year":"2022","unstructured":"Chen H, Yu Y, Yang M, et al. YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner. Cell Biosci. 2022;12(1):19. https:\/\/doi.org\/10.1186\/s13578-022-00759-w.","journal-title":"Cell Biosci"},{"issue":"1","key":"5771_CR85","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.molcel.2019.07.016","volume":"76","author":"YG Chen","year":"2019","unstructured":"Chen YG, Chen R, Ahmad S, et al. N6-Methyladenosine modification controls circular RNA immunity. Mol Cell. 2019;76(1):96-109.e9. https:\/\/doi.org\/10.1016\/j.molcel.2019.07.016.","journal-title":"Mol Cell"},{"key":"5771_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.635329","volume":"11","author":"XY Dai","year":"2021","unstructured":"Dai XY, Shi L, Li Z, Yang HY, Wei JF, Ding Q. Main N6-methyladenosine readers: YTH family proteins in cancers. Front Oncol. 2021;11: 635329. https:\/\/doi.org\/10.3389\/fonc.2021.635329.","journal-title":"Front Oncol"},{"issue":"15","key":"5771_CR87","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1016\/j.molcel.2021.06.014","volume":"81","author":"JM Einstein","year":"2021","unstructured":"Einstein JM, Perelis M, Chaim IA, et al. Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer. Mol Cell. 2021;81(15):3048-3064.e9. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.014.","journal-title":"Mol Cell"},{"key":"5771_CR88","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1016\/j.csbj.2022.05.051","volume":"20","author":"L Sui","year":"2022","unstructured":"Sui L, Sanders A, Jiang WG, Ye L. Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. Comput Struct Biotechnol J. 2022;20:2745\u201358. https:\/\/doi.org\/10.1016\/j.csbj.2022.05.051.","journal-title":"Comput Struct Biotechnol J"},{"issue":"7","key":"5771_CR89","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1021\/acs.chemrestox.1c00206","volume":"34","author":"X Liu","year":"2021","unstructured":"Liu X, Yuan J, Zhang X, et al. ATF3 modulates the resistance of breast cancer cells to tamoxifen through an N(6)-methyladenosine-based epitranscriptomic mechanism. Chem Res Toxicol. 2021;34(7):1814\u201321. https:\/\/doi.org\/10.1021\/acs.chemrestox.1c00206.","journal-title":"Chem Res Toxicol"},{"issue":"4","key":"5771_CR90","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.ajpath.2022.12.010","volume":"193","author":"X Li","year":"2023","unstructured":"Li X, Zhang K, Hu Y, Luo N. YTHDF2 regulates cell growth and cycle by facilitating KDM1A mRNA stability. Am J Pathol. 2023;193(4):442\u201355. https:\/\/doi.org\/10.1016\/j.ajpath.2022.12.010.","journal-title":"Am J Pathol"},{"issue":"1","key":"5771_CR91","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12967-021-03196-4","volume":"19","author":"W Lv","year":"2021","unstructured":"Lv W, Tan Y, Xiong M, et al. Analysis and validation of m6A regulatory network: a novel circBACH2\/has-miR-944\/HNRNPC axis in breast cancer progression. J Transl Med. 2021;19(1):527. https:\/\/doi.org\/10.1186\/s12967-021-03196-4.","journal-title":"J Transl Med"},{"key":"5771_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.756412","volume":"11","author":"G Zhao","year":"2021","unstructured":"Zhao G, An J, Pu Q, et al. Gene signatures and cancer-immune phenotypes based on m(6)A regulators in breast cancer. Front Oncol. 2021;11: 756412. https:\/\/doi.org\/10.3389\/fonc.2021.756412.","journal-title":"Front Oncol"},{"key":"5771_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.874532","volume":"9","author":"J Liu","year":"2022","unstructured":"Liu J, Zhu J, Wang X, Zhou Z, Liu H, Zhu D. A novel YTHDF3-based model to predict prognosis and therapeutic response in breast cancer. Front Mol Biosci. 2022;9: 874532. https:\/\/doi.org\/10.3389\/fmolb.2022.874532.","journal-title":"Front Mol Biosci"},{"issue":"2","key":"5771_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.21037\/atm-21-6857","volume":"10","author":"Y Lin","year":"2022","unstructured":"Lin Y, Jin X, Nie Q, et al. YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner. Ann Transl Med. 2022;10(2):83. https:\/\/doi.org\/10.21037\/atm-21-6857.","journal-title":"Ann Transl Med"},{"issue":"16","key":"5771_CR95","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1016\/j.molcel.2021.06.023","volume":"81","author":"J Akhtar","year":"2021","unstructured":"Akhtar J, Renaud Y, Albrecht S, et al. m(6)A RNA methylation regulates promoter-proximal pausing of RNA polymerase II. Mol Cell. 2021;81(16):3356-3367.e6. https:\/\/doi.org\/10.1016\/j.molcel.2021.06.023.","journal-title":"Mol Cell"},{"issue":"11","key":"5771_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001885","volume":"20","author":"AM Porman","year":"2022","unstructured":"Porman AM, Roberts JT, Duncan ED, et al. A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells. PLoS Biol. 2022;20(11): e3001885. https:\/\/doi.org\/10.1371\/journal.pbio.3001885.","journal-title":"PLoS Biol"},{"issue":"6","key":"5771_CR97","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/cas.16137","volume":"115","author":"X Shen","year":"2024","unstructured":"Shen X, Zhong J, Yu P, Liu F, Peng H, Chen N. YTHDC1-dependent m6A modification modulated FOXM1 promotes glycolysis and tumor progression through CENPA in triple-negative breast cancer. Cancer Sci. 2024;115(6):1881\u201395. https:\/\/doi.org\/10.1111\/cas.16137.","journal-title":"Cancer Sci"},{"issue":"13","key":"5771_CR98","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.7150\/thno.71872","volume":"12","author":"B Tan","year":"2022","unstructured":"Tan B, Zhou K, Liu W, et al. RNA N(6)-methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancer. Theranostics. 2022;12(13):5727\u201343. https:\/\/doi.org\/10.7150\/thno.71872.","journal-title":"Theranostics"},{"key":"5771_CR99","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.611191","volume":"10","author":"L Yang","year":"2020","unstructured":"Yang L, Wu S, Ma C, et al. RNA m(6)A methylation regulators subclassify luminal subtype in breast cancer. Front Oncol. 2020;10: 611191. https:\/\/doi.org\/10.3389\/fonc.2020.611191.","journal-title":"Front Oncol"},{"issue":"3.4","key":"5771_CR100","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2152\/jmi.68.213","volume":"68","author":"Y Bando","year":"2021","unstructured":"Bando Y, Kobayashi T, Miyakami Y, et al. Triple-negative breast cancer and basal-like subtype: pathology and targeted therapy. J Med Investig. 2021;68(3.4):213\u20139. https:\/\/doi.org\/10.2152\/jmi.68.213.","journal-title":"J Med Investig"},{"issue":"1","key":"5771_CR101","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"TY Zhu","year":"2023","unstructured":"Zhu TY, Hong LL, Ling ZQ. Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomark Res. 2023;11(1):62. https:\/\/doi.org\/10.1186\/s40364-023-00499-0.","journal-title":"Biomark Res"},{"issue":"8","key":"5771_CR102","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/s41419-021-04038-3","volume":"12","author":"Y Ying","year":"2021","unstructured":"Ying Y, Ma X, Fang J, et al. EGR2-mediated regulation of m(6)A reader IGF2BP proteins drive RCC tumorigenesis and metastasis via enhancing S1PR3 mRNA stabilization. Cell Death Dis. 2021;12(8):750. https:\/\/doi.org\/10.1038\/s41419-021-04038-3.","journal-title":"Cell Death Dis"},{"issue":"12","key":"5771_CR103","doi-asserted-by":"publisher","first-page":"11838","DOI":"10.1021\/acsnano.3c03050","volume":"17","author":"S Wu","year":"2023","unstructured":"Wu S, Yun J, Tang W, et al. Therapeutic m(6)A eraser ALKBH5 mRNA-loaded exosome-liposome hybrid nanoparticles inhibit progression of colorectal cancer in preclinical tumor models. ACS Nano. 2023;17(12):11838\u201354. https:\/\/doi.org\/10.1021\/acsnano.3c03050.","journal-title":"ACS Nano"},{"issue":"11","key":"5771_CR104","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200751RR","volume":"36","author":"T Jiang","year":"2022","unstructured":"Jiang T, He X, Zhao Z, Zhang X, Wang T, Jia L. RNA m6A reader IGF2BP3 promotes metastasis of triple-negative breast cancer via SLIT2 repression. Faseb J. 2022;36(11): e22618. https:\/\/doi.org\/10.1096\/fj.202200751RR.","journal-title":"Faseb J"},{"issue":"6","key":"5771_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e28243","volume":"10","author":"D Chen","year":"2024","unstructured":"Chen D, Zang L, Zhou Y, et al. IGF2BP2-related modification patterns in pancreatic cancer: a machine learning-driven approach towards personalized treatment. Heliyon. 2024;10(6): e28243. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28243.","journal-title":"Heliyon"},{"issue":"1","key":"5771_CR106","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13045-018-0628-y","volume":"11","author":"X Huang","year":"2018","unstructured":"Huang X, Zhang H, Guo X, Zhu Z, Cai H, Kong X. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer. J Hematol Oncol. 2018;11(1):88. https:\/\/doi.org\/10.1186\/s13045-018-0628-y.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"5771_CR107","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, Chen L, Qiang P. The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers. Cancer Cell Int. 2021;21(1):99. https:\/\/doi.org\/10.1186\/s12935-021-01799-x.","journal-title":"Cancer Cell Int"},{"issue":"3","key":"5771_CR108","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41422-020-00397-2","volume":"31","author":"F Peng","year":"2021","unstructured":"Peng F, Xu J, Cui B, et al. Oncogenic AURKA-enhanced N(6)-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells. Cell Res. 2021;31(3):345\u201361. https:\/\/doi.org\/10.1038\/s41422-020-00397-2.","journal-title":"Cell Res"},{"issue":"11","key":"5771_CR109","doi-asserted-by":"publisher","first-page":"9423","DOI":"10.3390\/ijms24119423","volume":"24","author":"X Liu","year":"2023","unstructured":"Liu X, Chen J, Chen W, Xu Y, Shen Y, Xu X. Targeting IGF2BP3 in cancer. Int J Mol Sci. 2023;24(11):9423. https:\/\/doi.org\/10.3390\/ijms24119423.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5771_CR110","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/cam4.2675","volume":"9","author":"G Bao","year":"2020","unstructured":"Bao G, Huang J, Pan W, Li X, Zhou T. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA. Cancer Med. 2020;9(1):278\u201389. https:\/\/doi.org\/10.1002\/cam4.2675.","journal-title":"Cancer Med"},{"issue":"6","key":"5771_CR111","doi-asserted-by":"publisher","first-page":"7948","DOI":"10.1002\/jcp.28014","volume":"234","author":"Z Bi","year":"2019","unstructured":"Bi Z, Liu Y, Zhao Y, et al. A dynamic reversible RNA N(6)-methyladenosine modification: current status and perspectives. J Cell Physiol. 2019;234(6):7948\u201356. https:\/\/doi.org\/10.1002\/jcp.28014.","journal-title":"J Cell Physiol"},{"issue":"6","key":"5771_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.168","volume":"7","author":"R Singh","year":"2016","unstructured":"Singh R, Gupta SC, Peng WX, et al. Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis. Cell Death Dis. 2016;7(6): e2262. https:\/\/doi.org\/10.1038\/cddis.2016.168.","journal-title":"Cell Death Dis"},{"key":"5771_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114259","volume":"182","author":"M Sudhakaran","year":"2020","unstructured":"Sudhakaran M, Parra MR, Stoub H, Gallo KA, Doseff AI. Apigenin by targeting hnRNPA2 sensitizes triple-negative breast cancer spheroids to doxorubicin-induced apoptosis and regulates expression of ABCC4 and ABCG2 drug efflux transporters. Biochem Pharmacol. 2020;182: 114259. https:\/\/doi.org\/10.1016\/j.bcp.2020.114259.","journal-title":"Biochem Pharmacol"},{"issue":"23","key":"5771_CR114","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201899017","volume":"37","author":"Y Wu","year":"2018","unstructured":"Wu Y, Zhao W, Liu Y, et al. Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response. EMBO J. 2018;37(23): e99017. https:\/\/doi.org\/10.15252\/embj.201899017.","journal-title":"EMBO J"},{"issue":"23","key":"5771_CR115","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100923","volume":"37","author":"SL Sarbanes","year":"2018","unstructured":"Sarbanes SL, Le Pen J, Rice CM. Friend and foe, HNRNPC takes on immunostimulatory RNAs in breast cancer cells. EMBO J. 2018;37(23): e100923. https:\/\/doi.org\/10.15252\/embj.2018100923.","journal-title":"EMBO J"},{"issue":"1","key":"5771_CR116","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s10020-023-00696-5","volume":"29","author":"B Lian","year":"2023","unstructured":"Lian B, Yan S, Li J, Bai Z, Li J. HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A\/DDR1 axis. Mol Med. 2023;29(1):103. https:\/\/doi.org\/10.1186\/s10020-023-00696-5.","journal-title":"Mol Med"},{"issue":"18","key":"5771_CR117","doi-asserted-by":"publisher","first-page":"8615","DOI":"10.1111\/jcmm.16818","volume":"25","author":"C Zhang","year":"2021","unstructured":"Zhang C, Guo C, Li Y, Ouyang L, Zhao Q, Liu K. The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer. J Cell Mol Med. 2021;25(18):8615\u201327. https:\/\/doi.org\/10.1111\/jcmm.16818.","journal-title":"J Cell Mol Med"},{"key":"5771_CR118","doi-asserted-by":"publisher","first-page":"1325615","DOI":"10.3389\/fimmu.2023.1325615","volume":"14","author":"J Yin","year":"2023","unstructured":"Yin J, Gu T, Chaudhry N, Davidson NE, Huang Y. Epigenetic modulation of antitumor immunity and immunotherapy response in breast cancer: biological mechanisms and clinical implications. Front Immunol. 2023;14:1325615. https:\/\/doi.org\/10.3389\/fimmu.2023.1325615.","journal-title":"Front Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05771-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05771-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T18:04:18Z","timestamp":1730138658000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05771-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5771"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05771-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"11 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"971"}}